secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARVINAS, INC. (ARVN)
CIK:        0001655759
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001655759-22-000073
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arvinas board: Brad Margus resigns, Everett Cunningham appointed; Loomis named principal accounting officer
--------------------------------------------------------------------------------

- Brad Margus resigned from board effective Dec 15, 2022; not due to any disagreement.
- Everett Cunningham appointed to board (Class III) and Audit Committee; receives $40k annual cash, $10k audit committee fee, stock option with $750k grant date fair value at $37.15.
- David Loomis named principal accounting officer; base salary $375k, bonus target 35%, sign-on $175k, option for 27,500 shares at $41.39, RSU 2,750 shares.
- Loomis previously VP & Corporate Controller at Biohaven, supported IPO and sale to Pfizer.
- Cunningham is CCO at Exact Sciences, former GE Healthcare and Pfizer executive.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1655759/000165575922000073/0001655759-22-000073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1655759/000165575922000073/arvn-20221214.htm
  HTML page:      https://secwatch.observer/filing/0001655759-22-000073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer